Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Cardiovasc Pharmacol ; 57(6): 648-55, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21346595

RESUMO

Because adrenergic contractions can contribute to the development of life-threatening spasm of coronary artery bypass graft, this study was performed to investigate the effect of adenosine 3-phosphate (ATP)-sensitive K channel (KATP) opener P1075 on contractions of isolated human saphenous vein (HSV) and human internal mammary artery (HIMA). Phasic contractions were evoked by electric field stimulation (20 Hz) and noradrenaline. The sustained contractions were evoked by phenylephrine. The presence of pore-forming Kir6.1 and Kir6.2 subunits of the KATP channels in the HIMA and only Kir6.2 in the HSV was confirmed immunomorphologically. P1075 inhibited in the HSV only, the electrical field stimulation contractions more strongly than noradrenaline contractions. In addition, the phenylephrine contractions of HSV were more sensitive to P1075 in comparison to those of HIMA. Glibenclamide, a KATP channel blocker antagonized the vasodilatation produced by P1075 in both grafts differently, because its effect was more prominent on the P1075-induced inhibition of contractions of HSV than of HIMA. We conclude that P1075 has a vasorelaxant effect and inhibited adrenergic contractions of the tested grafts. This effect is graft and vasoconstrictor selective and seems to be mediated by Kir6.1- and/or Kir6.2-containing KATP channels. Thus, P1075 can be considered as a potential drug in the prevention of graft spasm.


Assuntos
Guanidinas/farmacologia , Canais KATP/agonistas , Artéria Torácica Interna/efeitos dos fármacos , Piridinas/farmacologia , Veia Safena/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos , Vasodilatadores/farmacologia , Idoso , Estimulação Elétrica , Glibureto/farmacologia , Guanidinas/antagonistas & inibidores , Humanos , Canais KATP/metabolismo , Masculino , Artéria Torácica Interna/citologia , Artéria Torácica Interna/metabolismo , Pessoa de Meia-Idade , Técnicas de Cultura de Órgãos , Especificidade de Órgãos , Concentração Osmolar , Bloqueadores dos Canais de Potássio/farmacologia , Canais de Potássio Corretores do Fluxo de Internalização/metabolismo , Subunidades Proteicas/metabolismo , Piridinas/antagonistas & inibidores , Veia Safena/citologia , Veia Safena/metabolismo , Vasoconstrição/efeitos dos fármacos , Vasodilatadores/antagonistas & inibidores
2.
J Chromatogr Sci ; 48(3): 229-34, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-20223091

RESUMO

Resveratrol (trans-3,5,4'-trihydroxystilbene) is a phytoalexin produced by grapevines in response to fungal infection, particularly to Botrytis cinerea. It has been shown that it possess various biological effects such as prevention of cardiovascular diseases and anti-inflammatory and anticancerogenic properties. Red wines are a primary source of resveratrol. Although a number of investigations have focused on the determination of resveratrol in wines of different countries, there is no similar study about the wines produced in Serbia. As authors are aware, the only study concerning resveratrol content in wine in the Balkan region was conducted in Greece. In this study, the trans- and cis-resveratrol content in samples obtained from 18 commercial Serbian wines (10 red, 7 white, and 1 rose) were analyzed. Analyses were performed after solid-phase extraction by high-performance liquid chromatography with a diode array detection system using an RP-C(18) column with gradient elution [solvent A: acetonitrile-acetic acid-water (20:2:78 v/v), solvent B: acetonitrile-acetic acid-water (90:2:8 v/v)]. Detection of trans- and cis-resveratrol was performed on 306 and 286 nm, respectively. It was clearly established that there was a presence of trans-resveratrol isomers in all analyzed wines (0.11-1.69 mg/L) except in one white wine. Cis-resveratrol was present in 12 from 18 samples in different amounts (0.12-1.49 mg/L).


Assuntos
Anti-Inflamatórios não Esteroides/análise , Antineoplásicos Fitogênicos/análise , Estilbenos/análise , Vinho/análise , Anti-Inflamatórios não Esteroides/química , Antineoplásicos Fitogênicos/química , Cromatografia Líquida de Alta Pressão , Resveratrol , Sérvia , Extração em Fase Sólida , Estilbenos/química
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA